Tengion (TNGN) Files $40.25M IPO
Tweet Send to a FriendGet Alerts TNGN Hot Sheet
Trade TNGN Now!
Tengion (Nasdaq: TNGN) filed a registration statement with the SEC for an initial public offering of its common stock. The proposed maximum aggregate offering price is $40.25 million. The company plans to list on the NASDAQ under the stock symbol "TNGN".
The offering is being made through Piper Jaffray.
Tengion is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues.
The offering is being made through Piper Jaffray.
Tengion is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues.
You May Also Be Interested In
- Friday's Hot IPOs Get Even Hotter (MKTO) (DATA)
- Tengion Provides Business Update and Reports First Quarter 2013 Financial Results
- Marketo (MKTO) IPO Opens 54% Higher
Create E-mail Alert Related Categories
IPOsRelated Entities
Piper Jaffray
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
